MedPath

Phase3,Randomized,Double-Blinded,Clinical Trial of NPC-01 for Treatment of Dysmenorrhea.

Phase 3
Conditions
dysmenorrhea
Registration Number
JPRN-jRCT2080221084
Lead Sponsor
obelpharma Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

dysmenorrhea

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath